Markets:

Overview

News

Currencies

International

Treasuries

Phreesia, Inc. Common Stock (NY:PHR)

20.36 +0.31 (+1.57%)

Streaming Delayed Price Updated: 12:56 PM EST, Nov 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Phreesia, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >

Capricorn Fund Loads Up on Phreesia (PHR) With a 484,000 Share Purchase ↗

October 27, 2025

Capricorn Fund Loads Up on Phreesia (PHR) With a 484,000 Share Purchase

Via The Motley Fool

Phreesia Analysts Raise Their Forecasts After Q2 Results ↗

September 05, 2025

Via Benzinga

Analysts Weigh Integration Risks As Phreesia Expands With New Deal ↗

September 05, 2025

Phreesia gains analyst support with price target hikes, though integration risks and modest guidance raise tempered investor enthusiasm.

Via Benzinga

Beyond The Numbers: 6 Analysts Discuss Phreesia Stock ↗

September 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 05, 2025

Via Benzinga

An Overview of Phreesia's Earnings ↗

September 03, 2025

Via Benzinga

Where Phreesia Stands With Analysts ↗

May 29, 2025

Via Benzinga

What to Expect from Phreesia's Earnings ↗

May 27, 2025

Via Benzinga

Phreesia PHR Q2 2026 Earnings Call Transcript ↗

September 04, 2025

Via The Motley Fool

Topics Artificial Intelligence Earnings

Phreesia Reports First Net Income Gain ↗

September 04, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 04, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

September 04, 2025

After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Phreesia Posts 15% Revenue Gain in Q2 ↗

September 04, 2025

Via The Motley Fool

Earnings Scheduled For September 4, 2025 ↗

September 04, 2025

Via Benzinga

3 Red-Hot Growth Stocks to Buy in 2025 ↗

July 25, 2025

Via The Motley Fool

Topics Retirement

What 4 Analyst Ratings Have To Say About Phreesia ↗

July 14, 2025

Via Benzinga

Q1 Earnings Outperformers: Phreesia (NYSE:PHR) And The Rest Of The Healthcare Technology for Providers Stocks

May 29, 2025

Looking back on healthcare technology for providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Phreesia (NYSE:PHR) and its peers.

Via StockStory

PHR Q1 Earnings Call: Profitability Surges Amid Product Expansion

May 28, 2025

Healthcare technology company Phreesia (NYSE:PHR) exceeded Wall Street’s revenue expectations in Q1 CY2025, as sales rose 14.5% year on year to $115.9 million. Its GAAP loss of $0.07 per share...

Via StockStory

Topics Artificial Intelligence

PHR Q1 Earnings Call: Revenue Misses, Profitability Surges Amid Product Expansion

May 28, 2025

Healthcare technology company Phreesia (NYSE:PHR) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 14.5% year on year to $115.9 million. Its GAAP loss of $0.07 per share increased...

Via StockStory

Topics Artificial Intelligence

Phreesia (NYSE:PHR) Surprises With Q1 Sales

May 28, 2025

Healthcare technology company Phreesia (NYSE:PHR) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 14.5% year on year to $115.9 million. The company expects the...

Via StockStory

Earnings Scheduled For May 28, 2025 ↗

May 28, 2025

Via Benzinga

Phreesia (PHR) Reports Q1: Everything You Need To Know Ahead Of Earnings

May 27, 2025

Healthcare technology company Phreesia (NYSE:PHR) will be reporting results tomorrow after market hours. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

3 of Wall Street’s Favorite Stocks Skating on Thin Ice

May 12, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

1 Cash-Heavy Stock with Impressive Fundamentals and 2 to Ignore

April 29, 2025

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,...

Via StockStory

Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks

April 29, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (NYSE:EVH) and...

Via StockStory

Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks

April 28, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (NASDAQ:OMCL) and the best and...

Via StockStory

Q4 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks

April 25, 2025

Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Premier (NASDAQ:PINC) and its peers.

Via StockStory

Topics Economy

Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers

April 17, 2025

Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.

Via StockStory

Q4 Rundown: Astrana Health (NASDAQ:ASTH) Vs Other Healthcare Technology for Providers Stocks

April 16, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers.

Via StockStory

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

April 15, 2025

Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.

Via StockStory

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions